---
title: OpenAI's Sam Altman May Back Startup to Rival Neuralink
date: '2025-08-13 01:04:44 '
categories:
- Emerging Technologies
tags:
- ai
- startups
- brain-computer-interface
- neuralink
- openai-fund
excerpt: Sam Altman's OpenAI may back Merge Labs, a startup challenging Elon Musk's
  Neuralink in the brain-computer interface race. Learn about the future of BCIs.
toc: true
toc_sticky: true
classes: wide
keywords:
- AI
- brain-computer interface
- Neuralink
- OpenAI
- Sam Altman
- Merge Labs
- Elon Musk
- BCI
- singularity
---

## OpenAI's Sam Altman Reportedly Eyeing Neuralink Competitor: Merge Labs

The race to unlock the potential of brain-computer interfaces (BCIs) is heating up! According to reports, Sam Altman, the CEO of OpenAI, is potentially backing a new startup called Merge Labs, aimed at directly competing with Elon Musk's Neuralink. This move could significantly impact the future of how humans interact with technology and even accelerate the path towards a more integrated human-machine future.

### What We Know About Merge Labs

While details are still emerging, here's what's been reported about Merge Labs:

*   **Focus:** Developing brain-to-computer interfaces, similar to Neuralink.
*   **Potential Valuation:** Expected to be valued around $850 million.
*   **Funding:** OpenAI's ventures team is a possible major investor.
*   **Collaboration:** Reportedly working with Alex Blania, known for his work with Tools for Humanity (formerly Worldcoin), Altman's eye-scanning digital ID project.

It's important to note that the deal is still in early stages, and OpenAI has not yet officially committed to participating. Terms are subject to change.

### Neuralink: The Current Leader in the BCI Race

Elon Musk's Neuralink has been making significant strides in the BCI field. Founded in 2016, the company is developing implantable computer interface chips designed to allow individuals to control devices with their thoughts. Currently, Neuralink is conducting trials with people suffering from severe paralysis, with the goal of enabling them to regain control and independence.

In June, Neuralink raised a $600 million Series E round, valuing the company at a staggering $9 billion.

### Why This Matters: The Singularity and the Future of Humanity

Both Neuralink and, potentially, Merge Labs are working on technology that could fundamentally change the human experience. The potential applications are vast, ranging from treating neurological disorders to enhancing human capabilities. Some even believe that BCIs could be a key step towards "the singularity" – a hypothetical point in time when technological growth becomes uncontrollable and irreversible, resulting in unfathomable changes to human civilization.

While the term "singularity" is often associated with AI surpassing human intelligence (a concept Musk has frequently discussed), it also refers to the merging of technology with humans. As Altman himself wrote in 2017, "Although the merge has already begun, it’s going to get a lot weirder. We will be the first species ever to design our own descendants."

### The Altman-Musk Rivalry: A Driving Force?

The potential backing of Merge Labs by Altman adds another layer to the ongoing rivalry between him and Elon Musk. Musk, who co-founded OpenAI, left the company in 2018, and their relationship has become increasingly strained. Recent public disagreements on social media platform X (formerly Twitter) highlight the tension between the two tech leaders. It's plausible that Altman's interest in Merge Labs is, in part, driven by a desire to challenge Musk in this critical area of technological development.

### Actionable Takeaway:

*   **Stay informed:** Keep an eye on developments in the BCI space. This technology has the potential to dramatically impact various industries, including healthcare, gaming, and communication. Follow companies like Neuralink and watch for official announcements regarding Merge Labs.

### The Big Picture

Whether Merge Labs becomes a reality remains to be seen. However, the prospect of OpenAI backing a Neuralink competitor underscores the growing importance of brain-computer interfaces and the potential they hold for the future. This development also highlights the intense competition and innovation that are characteristic of the tech industry, particularly in the fields of AI and emerging technologies.

[Include a relevant image here if available]

### FAQ About Brain-Computer Interfaces

*   **What is a brain-computer interface (BCI)?**
    A BCI is a technology that allows direct communication between the brain and an external device, such as a computer or prosthetic limb.
*   **How do BCIs work?**
    BCIs typically involve recording brain activity using sensors (either implanted or non-invasive) and translating that activity into commands that can control external devices.
*   **What are the potential applications of BCIs?**
    BCIs have a wide range of potential applications, including treating neurological disorders, restoring movement to paralyzed individuals, enhancing human capabilities, and enabling new forms of communication.
*   **What are the ethical concerns surrounding BCIs?**
    Ethical concerns include privacy, security, potential for misuse, and the impact on human identity and autonomy.

### Key Takeaways

*   Sam Altman is reportedly considering backing Merge Labs, a startup aiming to compete with Neuralink.
*   Brain-computer interfaces have the potential to revolutionize how humans interact with technology.
*   The development highlights the ongoing rivalry between Altman and Musk and the intense competition in the tech industry.
*   The technology is still in early stages, and the long-term impact remains uncertain.

---

Source: [TechCrunch](https://techcrunch.com/2025/08/12/sam-altman-openai-will-reportedly-back-a-startup-that-takes-on-musks-neuralink/)